Suppr超能文献

改造微生物群以实现黏膜免疫接种:应用表达破伤风毒素片段C的乳酸杆菌进行黏膜给药后血清免疫球蛋白G反应及活化的引流颈淋巴结

Engineering the microflora to vaccinate the mucosa: serum immunoglobulin G responses and activated draining cervical lymph nodes following mucosal application of tetanus toxin fragment C-expressing lactobacilli.

作者信息

Shaw D M, Gaerthé B, Leer R J, Van Der Stap J G, Smittenaar C, Heijne Den Bak-Glashouwer M, Thole J E, Tielen F J, Pouwels P H, Havenith C E

机构信息

TNO-Prevention and Health, Special Program Infectious Diseases, Zernikedreef, Leiden, The Netherlands.

出版信息

Immunology. 2000 Aug;100(4):510-8. doi: 10.1046/j.1365-2567.2000.00069.x.

Abstract

The delivery of antigens to mucosal-associated lymphoid tissues in paediatric and immunocompromised populations by safe, non-invasive vectors, such as commensal lactobacilli, represents a crucial improvement to prevailing vaccination options. In this report, we describe the oral and nasal immunization of mice with vaccines constructed through an original system for heterologous gene expression in Lactobacillus in which the 50 000-molecular weight (MW) fragment C of tetanus toxin (TTFC) is expressed either as an intracellular or a surface-exposed protein. Our data indicate that L. plantarum is more effective in this respect than L. casei and that, under the experimental conditions investigated, delivery of TTFC expressed as an intracellular antigen is more effective than cell-surface expression. Immunization of mice with live recombinant lactobacilli induced significant levels of circulating TTFC-specific immunoglobulin G (IgG) following nasal or oral delivery of vaccine strains. In addition, following nasal delivery, secretory immunoglobulin A (sIgA) was induced in bronchoalveolar lavage fluids, as were antigen-specific antibody-secreting cells and antigen-specific T-cell activation in draining lymph nodes, substantiating their potential for safe mucosal delivery of paediatric vaccines.

摘要

通过安全、非侵入性载体(如共生乳杆菌)将抗原递送至儿科和免疫功能低下人群的黏膜相关淋巴组织,是对现有疫苗接种选择的一项关键改进。在本报告中,我们描述了用通过一种用于在乳酸杆菌中进行异源基因表达的原始系统构建的疫苗对小鼠进行口服和鼻内免疫,其中破伤风毒素(TTFC)的50000分子量(MW)片段C被表达为细胞内蛋白或表面暴露蛋白。我们的数据表明,在这方面植物乳杆菌比干酪乳杆菌更有效,并且在所研究的实验条件下,作为细胞内抗原表达的TTFC的递送比细胞表面表达更有效。用活的重组乳杆菌对小鼠进行免疫,在经鼻或口服递送疫苗菌株后,诱导出显著水平的循环TTFC特异性免疫球蛋白G(IgG)。此外,经鼻递送后,支气管肺泡灌洗液中诱导出分泌型免疫球蛋白A(sIgA),引流淋巴结中也诱导出抗原特异性抗体分泌细胞和抗原特异性T细胞活化,证实了它们在安全黏膜递送儿科疫苗方面的潜力。

相似文献

引用本文的文献

2
Recent development of oral vaccines (Review).口服疫苗的最新进展(综述)
Exp Ther Med. 2024 Mar 22;27(5):223. doi: 10.3892/etm.2024.12511. eCollection 2024 May.
6
Engineering living therapeutics with synthetic biology.用合成生物学设计活体治疗药物。
Nat Rev Drug Discov. 2021 Dec;20(12):941-960. doi: 10.1038/s41573-021-00285-3. Epub 2021 Oct 6.

本文引用的文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验